Dana Dovey, Contributor

Author's posts

Injection That Makes Colorectal Cancer ‘Glow’ During Surgery Enters Phase 3 Trial

This injection would make colorectal cancer cells glow, therefore easier to find and surgically remove.

Mice Brains May Be Too Different From Humans’ To Be Accurate Research Model, Study Says

New research has found key differences between the cerebellum of mice and that of humans.

FDA Approves Cystic Fibrosis Drug Applicable For 90 Percent Of Patients

Trikafta is now approved for use in CF patients 12 years and older with at least one F508del mutation.

Eye Drops Proven To Reverse Vision Loss In Clinical Trial

Eye drops that reverse poor eye sight have passed the most recent clinical trials.

FDA Awards $4.1 Billion In Funding For Rare Disease Research

The FDA announced new funding this month, and will distribute money for rare disease research.

It May Be Time For Standard Breast Cancer Treatment To Change

New trial suggests that doctor’s shouldn’t wait to add targeted therapy drugs to standard breast cancer treatment.

Herpes Vaccine Candidate Moves Closer To Human Trials

Herpes is one of the most prevalent viruses in humans, but this may not always be the case.

Ketamine Depression Treatment Passes Another Trial, But Isn’t For Everyone

Esketamine based antidepressant treatment has passed yet another drug trial, but who should expect to be prescribed this fast-acting treatment.